Alzamend Neuro (ALZN) risk factors

Item 1A of every Alzamend Neuro, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open ALZN in Gloom →

Alzamend Neuro's chart, financials and news, free in your browser.Open ALZN in Gloom →

FY2026 10-K risk factors
52 risks1 new7 dropped5 reworded
Nasdaq stockholders’ equity compliance is now an explicit risk, with a September 16, 2026 deadline to regain compliance.
Filed Jul 22, 2026
FY2025 10-K risk factors
58 risks
Alzamend Neuro faces going concern doubts and needs substantial funding to develop its Alzheimer's candidates AL001 and ALZN002.
Filed Jul 22, 2025